Skip to content

    Krystal Biotech (KRYS) stock price & financials

    View KRYS earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+138.1% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $83.84M
    $91.14M
    $88.18M
    $96.04M
    $97.80M
    +16.6%
    $107.11M
    +17.5%
    $116.36M
    +31.9%
    $119.22M
    +24.1%
    Strengthening
    Operating Profit
    $22.47M
    $41.39M
    $36.25M
    $39.40M
    $41.37M
    +84.1%
    $44.27M
    +6.9%
    $53.69M
    +48.1%
    $58.42M
    +48.3%
    Strengthening
    Net Profit
    $27.18M
    $45.48M
    $35.73M
    $38.33M
    $79.36M
    +192.0%
    $51.40M
    +13.0%
    $55.93M
    +56.5%
    $54.77M
    +42.9%
    Strengthening
    EPS
    $0.95
    $1.24
    $1.33
    $2.74
    +188.4%
    $1.91
    +54.0%
    $1.85
    +39.1%
    Strengthening
    Other Income
    Interest
    Depreciation
    Profit before Tax
    $29.77M
    $48.61M
    $43.60M
    $46.77M
    $47.97M
    +61.1%
    $51.13M
    +5.2%
    $61.44M
    +40.9%
    $66.08M
    +41.3%
    Strengthening
    MarginsOPM
    26.8%
    45.4%
    41.1%
    41.0%
    42.3%
    +57.8%
    41.3%
    -9.0%
    46.1%
    +12.2%
    49.0%
    +19.5%
    Strengthening
    Tax
    8.7%
    6.4%
    18.0%
    18.1%
    -65.5%
    -852.4%
    -0.5%
    -108.1%
    9.0%
    -50.3%
    17.1%
    -5.2%
    Weakening
    ReturnsROIC
    20.2%
    33.7%
    26.5%
    28.4%
    58.8%
    +192.0%
    38.1%
    +13.0%
    41.5%
    +56.5%
    40.6%
    +42.9%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$103.67M$187.51M$268.27M$341.25M$161.90M$358.33M$344.87M$496.30M$427.74M
    Short-Term Investments
    Total Current Assets$112.65M$195.88M$275.06M$442.27M$383.78M$587.91M$742.04M$1.02B$1.06B
    Net PP&E$3.01M$11.18M$34.17M$119.58M$169.73M$168.23M$161.45M$158.01M$160.60M
    Goodwill
    Intangibles
    Total Assets$116.12M$209.02M$310.84M$626.29M$558.45M$818.36M$1.06B$1.33B$1.50B
    LiabilitiesTotal Current Liabilities$2.60M$3.33M$15.45M$25.74M$28.85M$33.09M$102.00M$102.94M$127.40M
    Short-Term Debt
    Long-Term Debt
    Long-Term Leases$2.78M$3.31M$6.98M$7.37M$6.62M$6.04M$7.57M$7.04M
    Total Liabilities$2.89M$6.11M$18.76M$32.72M$36.22M$39.71M$109.46M$114.23M$141.52M
    EquityCommon Stock & APIC$0$0$0$0$0$0$0$0$0
    Retained Earnings-$19.96M-$39.05M-$71.21M-$140.78M-$280.76M-$269.83M-$180.67M$24.16M$134.86M
    Total Equity$113.23M$202.91M$292.08M$593.58M$522.23M$778.64M$946.38M$1.22B$1.36B
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$9.45M-$18.69M-$26.08M-$47.94M-$100.57M-$88.80M$123.42M$200.87M$272.34M
    Cash from Investing-$10.32M-$4.99M-$11.18M-$226.77M-$114.08M$82.64M-$163.44M-$58.42M-$218.29M
    Cash from Financing$73.85M$107.53M$118.02M$347.69M$35.35M$202.75M$27.01M$8.71M$23.97M
    SummaryCapital Expenditure-$2.23M-$6.40M-$14.84M-$68.34M-$52.98M-$11.80M-$4.24M-$11.95M-$14.56M
    Free Cash Flow-$11.68M-$25.09M-$40.93M-$116.27M-$153.55M-$100.60M$119.18M$188.91M$257.78M
    FCF Margin-198.4%41.0%48.5%58.5%

    Ratios